Android app on Google Play

Harvard Bioscience, Inc. (HBIO) Misses Q4 EPS by 2c

February 28, 2013 7:46 AM EST Send to a Friend
Harvard Bioscience, Inc. (NASDAQ: HBIO) reported Q4 EPS of $0.02, $0.02 worse than the analyst estimate of $0.04. Revenue for the quarter came in at $28.2 million versus the consensus estimate of $29.2 million.

For earnings history and earnings-related data on Harvard Bioscience, Inc. (HBIO) click here.

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment